1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA02681671
d formulations for customers Follow-on markets include specialty medical phage for antibiotic resistant bacteria, gastrointestinal illnesses, etc. Second Product Development Class (Year 2): Synthetic Oncolytics One in three humans will get cancer in their lifetime. It is also the leading cause of death in dogs over the age of
No connected entities